Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomic Medicine, |
RCV001420385 | SCV001622445 | uncertain significance | Factor V deficiency | 2021-04-28 | criteria provided, single submitter | research | |
3billion | RCV001420385 | SCV002573016 | uncertain significance | Factor V deficiency | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.96; 3Cnet: 0.96). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with F5-related disorder (PMID: 31268865). However, the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. |